Mechanistic insights into the impairment of memory B cells and antibody production in the elderly

Age

Volumn 35, Issue 2, 2013, Pages 371-381

  Aberle, Judith H ^a,b   Stiasny, Karin ^a   Kundi, Michael ^a   Heinz, Franz X ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b not available   (Austria)

Author keywords

Aging; B memory cells; CD154; Immunosenescence; TBE vaccination

Indexed keywords

ANTIBODY; INTERLEUKIN 2; TICK BORNE ENCEPHALITIS VACCINE;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MEMORY CELL; PROSPECTIVE STUDY; REVACCINATION; TICK BORNE ENCEPHALITIS; VACCINATION;

EID: 84880570117     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-011-9371-9     Document Type: Article

References (49)

1. Amanna IJ, Slifka MK (2006) Quantitation of rare memory B cell populations by two independent and complementary approaches. J Immunol Methods 317(1-2):175-185
2. Aw D, Silva AB et al (2007) Immunosenescence: emerging challenges for an ageing population. Immunology 120(4):435-446
3. Barrett PN, Plotkin SA, Ehrlich HJ (2008) Tick-borne encephalitits virus vaccines. Vaccine. O. W. Plotkin SA, Offit PA, Saunders Elsevier, pp 841-856
4. Bernstein ED, Murasko DM (1998) Effect of age on cytokine production in humans. AGE 21:137-151
5. Blanchard-Rohner G, Pulickal AS et al (2009) Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans. Blood 114(24):4998-5002
6. Cancro MP, Hao Y et al (2009) B cells and aging: molecules and mechanisms. Trends Immunol 30(7):313-318
7. Chattopadhyay PK, Yu J et al (2006) Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression. Nat Protoc 1(1):1-6
8. Eaton SM, Burns EM et al (2004) Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med 200(12):1613-1622
9. Ennist DL, Jones KH et al (1986) Functional analysis of the immunosenescence of the human B cell system: dissociation of normal activation and proliferation from impaired terminal differentiation into IgM immunoglobulin-secreting cells. J Immunol 136(1):99-105
10. Franceschi C, Monti D et al (1995) The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 16(1):12-16
11. Frasca D, Blomberg BB (2011) Aging affects human B cell responses. J Clin Immunol 31(3):430-435
12. Frasca D, Landin AM et al (2008) Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 180(8):5283-5290
13. Goins CL, Chappell CP et al (2010) Immune complex-mediated enhancement of secondary antibody responses. J Immunol 184(11):6293-6298
14. Gubler DJ (2007) The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 45(8):1039-1046
15. Haglund M, Gunther G (2003) Tick-borne encephalitis - pathogenesis, clinical course and long-term follow-up. Vaccine 21(Suppl 1):S11-S18
16. Hainz U, Jenewein B et al (2005) Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 23(25):3232-3235
17. Halstead SB, Jacobson J (2008) Japanese encephalitis vaccines. Vaccine. O. W. Plotkin SA, Offit PA, Saunders Elsevier, pp 311-352
18. Haynes L, Eaton SM (2005) The effect of age on the cognate function of CD4+ T cells. Immunol Rev 205:220-228
19. Haynes L, Eaton SM et al (2003) CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A 100(25):15053-15058
20. Holzmann H, Kundi M et al (1996) Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol 48(1):102-107
21. Johnson SA, Cambier JC (2004) Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity. Arthritis Res Ther 6(4):131-139
22. Kaiser R (2002) Tick-borne encephalitis (TBE) in Germany and clinical course of the disease. Int J Med Microbiol 291(Suppl 33):58-61
23. Kallies A, Nutt SL (2007) Terminal differentiation of lymphocytes depends on Blimp-1. Curr Opin Immunol 19(2):156-162
24. Kaml M, Weiskirchner I et al (2006) Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. Vaccine 24(47-48):6808-6811
25. Kawabe T, Naka T et al (1994) The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1(3):167-178
26. Kreil TR, Maier E et al (1998) Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein. J Virol 72(4):3076-3081
27. Kyle JL, Harris E (2008) Global spread and persistence of dengue. Annu Rev Microbiol 62:71-92
28. Litjens NH, Huisman M et al (2008) IL-2 producing memory CD4+ T lymphocytes are closely associated with the generation of IgG-secreting plasma cells. J Immunol 181(5):3665-3673
29. Loew-Baselli A, Poellabauer EM et al (2009) Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years. Hum Vaccin 5(8):551-556
30. Manz RA, Thiel A et al (1997) Lifetime of plasma cells in the bone marrow. Nature 388(6638):133-134
31. McElhaney JE, Effros RB (2009) Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol 21(4):418-424
32. Mickiene A, Laiskonis A et al (2002) Tick-borne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis. Clin Infect Dis 35(6):650-658
33. Monath TP, Cetron M, Teuwen DE (2008). Yellow fever vaccine. Vaccine. O. W. Plotkin SA, Offit PA, Saunders Elsevier, pp 959-1055
34. Nicoletti C, Yang X et al (1993) Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol 150(2):543-549
35. Paulke-Korinek M, Rendi-Wagner P et al (2009) Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection. Vaccine 27(50):7027-7030
36. Pawelec G, Barnett Y et al (2002) T cells and aging, January 2002 update. Front Biosci 7:d1056-d1183
37. Pinna D, Corti D et al (2009) Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur J Immunol 39(5):1260-1270
38. Rendi-Wagner P, Zent O et al (2006) Persistence of antibodies after vaccination against tick-borne encephalitis. Int J Med Microbiol 296(Suppl 40):202-207
39. Shi Y, Yamazaki T et al (2005) Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol 175(5):3262-3267
40. Signer RA, Montecino-Rodriguez E et al (2007) Aging, B lymphopoiesis, and patterns of leukemogenesis. Exp Gerontol 42(5):391-395
41. Slifka MK, Antia R et al (1998) Humoral immunity due to long-lived plasma cells. Immunity 8(3):363-372
42. Steininger C, Rassenti LZ et al (2009) Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia. Eur J Clin Invest 39:497-506
43. Stiasny K, Holzmann H et al (2009) Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs. Vaccine 27(50):7021-7026
44. Swain S, Clise-Dwyer K et al (2005) Homeostasis and the age-associated defect of CD4 T cells. Semin Immunol 17(5):370-377
45. Turner CA Jr, Mack DH et al (1994) Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77(2):297-306
46. Weinberger B, Keller M et al (2010) Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years. Vaccine 28(20):3511-3515
47. Weksler ME, Hutteroth TH (1974) Impaired lymphocyte function in aged humans. J Clin Invest 53(1):99-104
48. Wolters B, Junge U et al (2003) Immunogenicity of combined hepatitis A and B vaccine in elderly persons. Vaccine 21(25-26):3623-3628
49. Xu J, Foy TM et al (1994) Mice deficient for the CD40 ligand. Immunity 1(5):423-431